Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Gland Papillary Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00095836
What this trial is testing

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

Who this might be right for
Head and Neck Cancer
Massachusetts General Hospital 27
Not applicableLooking for participantsNCT07140757
What this trial is testing

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Who this might be right for
Low RiskPapillary Thyroid CancerRadiofrequency Ablation
M.D. Anderson Cancer Center 50
Very early researchUnknownNCT01417442
What this trial is testing

BRAF V600E Mutations In Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma
Bezmialem Vakif University 150
Not applicableStudy completedNCT07391514
What this trial is testing

Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma
First Affiliated Hospital of Chongqing Medical University 131
Not applicableLooking for participantsNCT07218315
What this trial is testing

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
M.D. Anderson Cancer Center 15
Not applicableStudy completedNCT04594720
What this trial is testing

Circulating Biomarkers to Identify Thyroid Cancer

Who this might be right for
Thyroid CancerThyroid Cancer, PapillaryBenign Thyroid Tumor
Chang Gung Memorial Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07521670
What this trial is testing

Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

Who this might be right for
Recurrent Adenoid Cystic CarcinomaAdenoid Cystic Carcinoma MetastaticPapillary Thyroid Carcinoma
National Cancer Centre, Singapore 68
Early research (Phase 1)Study completedNCT00098943
What this trial is testing

NGR-TNF in Treating Patients With Advanced Solid Tumors

Who this might be right for
Colorectal CancerHead and Neck CancerKidney Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 70
Not applicableNot Yet RecruitingNCT06626581
What this trial is testing

Iodine Status and Characteristics of Papillary Thyroid Cancer

Who this might be right for
Papillary Thyroid Carcinoma
Shandong Provincial Hospital 600
Not applicableStudy completedNCT02442661
What this trial is testing

Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer

Who this might be right for
Papillary Thyroid Cancer
University of Colorado, Denver 103
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Testing effectiveness (Phase 2)Study completedNCT00519896
What this trial is testing

Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+5 more
University of Washington 35
Not applicableStudy completedNCT05752669
What this trial is testing

Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer.

Who this might be right for
Papillary Thyroid Cancer
Istituto Auxologico Italiano 100
Large-scale testing (Phase 3)Looking for participantsNCT06791005
What this trial is testing

A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

Who this might be right for
Papillary Thyroid Cancer
Second Affiliated Hospital of Xi'an Jiaotong University 400
Testing effectiveness (Phase 2)Study completedNCT00630214
What this trial is testing

Prevention of Hypocalcemia in Patients Undergoing Total Thyroidectomy Plus Central Neck Dissection

Who this might be right for
Hypocalcemia
Asan Medical Center 200
Testing effectiveness (Phase 2)Ended earlyNCT03753919
What this trial is testing

Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial

Who this might be right for
Metastatic Thyroid Papillary CarcinomaMetastatic Thyroid Follicular CarcinomaMetastatic Thyroid Cancer
Grupo Espanol de Tumores Neuroendocrinos 79
Not applicableLooking for participantsNCT06592755
What this trial is testing

Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC

Who this might be right for
Papillary Thyroid Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Testing effectiveness (Phase 2)Study completedNCT02973997
What this trial is testing

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

Who this might be right for
Columnar Cell Variant Thyroid Gland Papillary CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaMetastatic Thyroid Gland Follicular Carcinoma+23 more
Academic and Community Cancer Research United 57
Testing effectiveness (Phase 2)Looking for participantsNCT06440850
What this trial is testing

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

Who this might be right for
Thyroid Gland Follicular CarcinomaThyroid Gland Oncocytic CarcinomaThyroid Gland Papillary Carcinoma
City of Hope Medical Center 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03899792
What this trial is testing

Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

Who this might be right for
Medullary Thyroid CancerInfantile MyofibromatosisInfantile Fibrosarcoma+2 more
Eli Lilly and Company 36
Next Page